查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1497601

血液检测市场：按产品、检测类型、应用和最终用户 - 2024-2030 年全球预测

Blood Testing Market by Product (Instruments, Reagents & kits, Software), Test Type (Basic Metabolic Panels, Complete Blood Count Tests, Complete Metabolic Panels), Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年血液检测市场规模为1,000.2亿美元，2024年达1,060.1亿美元，预计2030年将达1,553.1亿美元，复合年增长率为6.48%。

血液检查是一种临床程序，在实验室中分析血液样本，以评估整体健康状况、检测病毒或细菌感染、确定各种器官的功能以及筛检遗传状况。血液检测是预防保健和医学诊断的重要工具，并包含早期发现和早期管理疾病的宝贵资料。血液检测应用于各医学领域。代谢功能的常规检测、感染疾病的增加以及对血液检测设施的持续投资正在推动对先进血液检测解决方案的需求。然而，严格的审批监管要求以及与先进测试技术相关的高成本可能会限制该产品的全球普及。此外，缺乏训练有素的专业人员来执行和解释复杂的血液检查可能会限制血液检测解决方案的使用。也就是说，测试技术的改进提供了更快、更准确、侵入性更小的测试，以及医疗基础设施和诊断支出的增加，预计将为血液检测市场在未来几年提供成长机会。

主要市场统计
基准年[2023] 1000.2亿美元
预测年份 [2024] 1060.1亿美元
预测年份 [2030] 1553.1亿美元
复合年增长率（%） 6.48%

区域洞察

美洲血液检测市场高度新兴，其特点是先进的医疗保健系统和消费者对健康状况的高度认识。慢性病的增加、人口老化以及大型医疗保健公司的出现正在推动对血液检测等诊断服务的需求。在欧盟 (EU) 国家，由于高医疗标准和国家医疗保健系统的存在，对血液检查的需求很高。人们对预防性医疗保健的兴趣日益浓厚，以及人口老化中慢性病的流行，正在推动市场的发展。此外，欧盟严格的法律规范确保了高品质的血液检测程序和设备标准。儘管中东地区由于卫生基础设施投资而正在经历快速发展，但非洲许多地区却面临血液检测产品的取得和负担能力等挑战。由于人口众多、医疗成本上升和快速都市化，亚太地区的血液检测市场正在快速成长。消费者友善血液检测产品的持续创新和市场开拓预计将推动亚太地区血液检测市场的发展。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在血液检测市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检查了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对血液检测市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外，该分析还提供了对该细分市场竞争力的宝贵见解，包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在血液检测市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行概述

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 个体自体免疫疾病的盛行率以及加强护理的需要
      • 政府推出验血健康检查宣传活动
      • 世界各地血液检测设施的显着扩张
    • 抑制因素
      • 原料成本波动与产品召回问题
    • 机会
      • 居家医疗和远端医疗的快速采用
      • 血液检测产品的进展
    • 任务
      • 与血液检测产品相关的皮肤穿刺不准确和安全问题
  • 市场区隔分析
    • 类型：血液检查中基本代谢组的显着渗透
    • 应用：增加血液检测套组在诊断自体免疫疾病的使用
    • 最终用户：血液检测产品在居家照护环境中的普及取得进展
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章血液检测市场：副产品

  • 介绍
  • 装置
  • 试剂和套件
  • 软体

第七章血液检测市场：依测试类型

  • 介绍
  • 基础代谢组
  • 全血球计数测试
  • 完整代谢组
  • 电解质板

第八章血液检测市场：依应用分类

  • 介绍
  • 过敏
  • 自体免疫疾病
  • 癌症/非癌症血液疾病
  • 内分泌系统疾病
  • 心臟疾病

第九章血液检测市场：依最终用户分类

  • 介绍
  • 血库
  • 诊断中心
  • 医院/诊所
  • 病理实验室

第十章美洲血液检测市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太血液检测市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲的血液检测市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Quest Diagnostics 宣布推出 P-Tau217 血液生物标记物，用于阿兹海默症风险评估和诊断支持
    • 巴布森诊断公司推出创新的零售血液检测服务
    • 日本卫材透过对 C2N Diagnostics 的策略性投资加强阿兹海默症检测
  • 战略分析和建议

第14章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-144C638C91DF

[199 Pages Report] The Blood Testing Market size was estimated at USD 100.02 billion in 2023 and expected to reach USD 106.01 billion in 2024, at a CAGR 6.48% to reach USD 155.31 billion by 2030.

Blood testing is a clinical procedure that involves analyzing a blood sample in a laboratory to assess the general state of health, detect the presence of viral or bacterial infections, determine the functioning of various organs, and screen for genetic conditions. Blood tests are critical tools for preventive medicine and medical diagnostics, providing valuable data for early disease detection and management. Blood tests have various applications in various medical and healthcare domains. Routine testing for metabolic functions, increasing prevalence of infectious disease, and ongoing investments in blood testing facilities have enhanced the need for advanced blood testing solutions. However, strict regulatory requirements for approval and high costs associated with advanced testing technologies may restrict product penetration worldwide. In addition, a lack of trained professionals to conduct and interpret complex blood tests may limit the use of blood testing solutions. Nevertheless, the improved testing technologies that provide quicker, more accurate, and less invasive testing and Increased spending on healthcare infrastructure and diagnostics are expected to create growth opportunities for the blood testing market in the coming years.

KEY MARKET STATISTICS
Base Year [2023] USD 100.02 billion
Estimated Year [2024] USD 106.01 billion
Forecast Year [2030] USD 155.31 billion
CAGR (%) 6.48%

Regional Insights

The blood testing market in the Americas is highly developing and characterized by advanced healthcare systems and higher consumer awareness of health conditions. A growing prevalence of chronic diseases, an aging population, and the presence of major healthcare companies elevate the need for diagnostic services such as blood testing. European Union (EU) countries exhibit a strong need for blood testing due to the high healthcare standards and the presence of national healthcare systems. An increasing focus on preventive care and the prevalence of chronic diseases among aging populations drives the market. Furthermore, the EU's stringent regulatory framework ensures high-quality blood testing procedures and equipment standards. The Middle East showcases rapid advancement due to investments in healthcare infrastructure, while many African regions face challenges, including accessibility and affordability of blood testing products. The Asia Pacific region represents a rapidly growing blood testing market due to large population bases, increasing healthcare expenditures, and rapid urbanization. The ongoing innovation and development of consumer-friendly blood testing products are expected to drive the blood testing market in Asia-Pacific.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Blood Testing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Prevalence of autoimmune disorders among individuals and need for enhanced care
      • Government initiatives in blood testing checkup campaigns
      • Significant expansion of blood testing facilities worldwide
    • Market Restraints
      • Changing costs of raw materials and issues of product recalls
    • Market Opportunities
      • Rapid adoption of home-based healthcare and telemedicine
      • Advancements in blood testing products
    • Market Challenges
      • Inaccuracy in skin puncture and safety issues associated with blood testing products
  • Market Segmentation Analysis
    • Type: Significant penetration of basic metabolic panels for blood testing
    • Application: Rising usage of blood testing kits for diagnosis of autoimmune diseases
    • End-User: Emerging penetration of blood testing products in home care settings
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Blood Testing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Blood Testing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Quest Diagnostics Introduces P-Tau217 Blood Biomarker for Alzheimer's Risk Assessment and Diagnostic Support

Quest Diagnostics expanded its health service offerings by including a new blood biomarker test, P-Tau217, aimed at enhancing the evaluation of Alzheimer's disease risk and aiding in its diagnosis. With the integration of P-Tau217 Blood Biomarker into their services, Quest Diagnostics provides critical insights into Alzheimer's disease. This development reflects Quest Diagnostics' commitment to advancing neurological health through innovative diagnostic solutions. [Published On: 2024-04-22]

Babson Diagnostics Launches Innovative Retail-Based Blood Testing Service

Babson Diagnostics, a healthcare technology company, announced the launch of a new blood testing service. This new service aims to make blood testing more accessible and convenient by integrating it within retail environments, thus allowing consumers to undergo testing while they shop. The initiative promises to enhance the customer experience by drastically reducing the blood needed for testing and shortening the turnaround time for results, leveraging advanced diagnostic technologies and a network of state-of-the-art labs. [Published On: 2024-03-21]

Japan's Eisai Enhances Alzheimer's Detection with Strategic Investment in C2N Diagnostics

Japan-based pharmaceutical company Eisai Co. has embarked on a strategic investment in C2N Diagnostics, a U.S. biotechnology that provides blood tests for Alzheimer's disease. This partnership aims to enhance the development and global distribution of C2N Diagnostics' innovative blood testing technology, which promises a less invasive, more accessible means of diagnosing Alzheimer's early. Eisai's investment aligns with its focus on neurological diseases and adds to its portfolio of treatments and diagnostics for Alzheimer's. [Published On: 2024-03-07]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Blood Testing Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Blood Testing Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l., Abbott Laboratories, ACON Laboratories, Inc., ARKRAY, Inc., B. Braun Melsungen AG, Becton Dickinson & Company, Bio-Rad Laboratories Inc., bioMerieux S.A., Danaher Corporation, F. Hoffmann-La Roche AG, Johnson & Johnson Services, Inc., Medtronic PLC, Merck KGaA, Nipro Corporation, Nova Biomedical Corporation, Novo Nordisk A/S, Omnipod by Insulet Corporation, Quest Diagnostic, Randox Laboratories Ltd., Siemens AG, Terumo Corporation, Thermo Fisher Scientific, Inc., Trinity Biotech PLC, Trividia Health, Inc., and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Blood Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Instruments
    • Reagents & kits
    • Software
  • Test Type
    • Basic Metabolic Panels
    • Complete Blood Count Tests
    • Complete Metabolic Panels
    • Electrolyte Panels
  • Application
    • Allergies
    • Autoimmune Diseases
    • Cancer/Noncancerous Blood Disorders
    • Endocrine System Disorders
    • Heart Diseases
  • End-User
    • Blood Banks
    • Diagnostic Centers
    • Hospital & Clinics
    • Pathology Labs
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of autoimmune disorders among individuals and need for enhanced care
      • 5.1.1.2. Government initiatives in blood testing checkup campaigns
      • 5.1.1.3. Significant expansion of blood testing facilities worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. Changing costs of raw materials and issues of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid adoption of home-based healthcare and telemedicine
      • 5.1.3.2. Advancements in blood testing products
    • 5.1.4. Challenges
      • 5.1.4.1. Inaccuracy in skin puncture and safety issues associated with blood testing products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Significant penetration of basic metabolic panels for blood testing
    • 5.2.2. Application: Rising usage of blood testing kits for diagnosis of autoimmune diseases
    • 5.2.3. End-User: Emerging penetration of blood testing products in home care settings
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Blood Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & kits
  • 6.4. Software

7. Blood Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Basic Metabolic Panels
  • 7.3. Complete Blood Count Tests
  • 7.4. Complete Metabolic Panels
  • 7.5. Electrolyte Panels

8. Blood Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Allergies
  • 8.3. Autoimmune Diseases
  • 8.4. Cancer/Noncancerous Blood Disorders
  • 8.5. Endocrine System Disorders
  • 8.6. Heart Diseases

9. Blood Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Blood Banks
  • 9.3. Diagnostic Centers
  • 9.4. Hospital & Clinics
  • 9.5. Pathology Labs

10. Americas Blood Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Blood Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Blood Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Quest Diagnostics Introduces P-Tau217 Blood Biomarker for Alzheimer's Risk Assessment and Diagnostic Support
    • 13.3.2. Babson Diagnostics Launches Innovative Retail-Based Blood Testing Service
    • 13.3.3. Japan's Eisai Enhances Alzheimer's Detection with Strategic Investment in C2N Diagnostics
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BLOOD TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BLOOD TESTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. BLOOD TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. BLOOD TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD TESTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD TESTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD TESTING MARKET SIZE, BY BASIC METABOLIC PANELS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD TESTING MARKET SIZE, BY BASIC METABOLIC PANELS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD TESTING MARKET SIZE, BY COMPLETE BLOOD COUNT TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD TESTING MARKET SIZE, BY COMPLETE BLOOD COUNT TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD TESTING MARKET SIZE, BY COMPLETE METABOLIC PANELS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD TESTING MARKET SIZE, BY COMPLETE METABOLIC PANELS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD TESTING MARKET SIZE, BY ELECTROLYTE PANELS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD TESTING MARKET SIZE, BY ELECTROLYTE PANELS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD TESTING MARKET SIZE, BY ALLERGIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD TESTING MARKET SIZE, BY ALLERGIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD TESTING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD TESTING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD TESTING MARKET SIZE, BY CANCER/NONCANCEROUS BLOOD DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD TESTING MARKET SIZE, BY CANCER/NONCANCEROUS BLOOD DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD TESTING MARKET SIZE, BY ENDOCRINE SYSTEM DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD TESTING MARKET SIZE, BY ENDOCRINE SYSTEM DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD TESTING MARKET SIZE, BY HEART DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD TESTING MARKET SIZE, BY HEART DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD TESTING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD TESTING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD TESTING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD TESTING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD TESTING MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD TESTING MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 81. MEXICO BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 82. MEXICO BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 89. UNITED STATES BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. UNITED STATES BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 110. AUSTRALIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. AUSTRALIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. AUSTRALIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 116. AUSTRALIA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 117. CHINA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 118. CHINA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 119. CHINA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. CHINA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. CHINA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. CHINA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. CHINA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. CHINA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. INDIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 126. INDIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 127. INDIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. INDIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. INDIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. INDIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. INDIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 132. INDIA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 133. INDONESIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 134. INDONESIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 135. INDONESIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. INDONESIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. INDONESIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. INDONESIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. INDONESIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. INDONESIA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. JAPAN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 142. JAPAN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 143. JAPAN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. JAPAN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. JAPAN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. JAPAN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. JAPAN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. JAPAN BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. MALAYSIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 150. MALAYSIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 151. MALAYSIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. MALAYSIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. MALAYSIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. MALAYSIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. MALAYSIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 156. MALAYSIA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 158. PHILIPPINES BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. PHILIPPINES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. PHILIPPINES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 164. PHILIPPINES BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 165. SINGAPORE BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 166. SINGAPORE BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 167. SINGAPORE BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. SINGAPORE BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. SINGAPORE BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. SINGAPORE BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. SINGAPORE BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. SINGAPORE BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 174. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. TAIWAN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 182. TAIWAN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 183. TAIWAN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. TAIWAN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. TAIWAN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. TAIWAN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. TAIWAN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 188. TAIWAN BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 189. THAILAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 190. THAILAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 191. THAILAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. THAILAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. THAILAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. THAILAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. THAILAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. THAILAND BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. VIETNAM BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 198. VIETNAM BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 199. VIETNAM BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. VIETNAM BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. VIETNAM BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. VIETNAM BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. VIETNAM BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. VIETNAM BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 215. DENMARK BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 216. DENMARK BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 217. DENMARK BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. DENMARK BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. DENMARK BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. DENMARK BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. DENMARK BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. DENMARK BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. EGYPT BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 224. EGYPT BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 225. EGYPT BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. EGYPT BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. EGYPT BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. EGYPT BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. EGYPT BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. EGYPT BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. FINLAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 232. FINLAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 233. FINLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. FINLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. FINLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. FINLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. FINLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 238. FINLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 239. FRANCE BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 240. FRANCE BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 241. FRANCE BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. FRANCE BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. FRANCE BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. FRANCE BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. FRANCE BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. FRANCE BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. GERMANY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 248. GERMANY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 249. GERMANY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. GERMANY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. GERMANY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. GERMANY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. GERMANY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 254. GERMANY BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 255. ISRAEL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 256. ISRAEL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 257. ISRAEL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. ISRAEL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. ISRAEL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. ISRAEL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. ISRAEL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 262. ISRAEL BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 263. ITALY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 264. ITALY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 265. ITALY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. ITALY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. ITALY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. ITALY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. ITALY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. ITALY BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 272. NETHERLANDS BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. NETHERLANDS BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. NETHERLANDS BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. NETHERLANDS BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 278. NETHERLANDS BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 279. NIGERIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 280. NIGERIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 281. NIGERIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. NIGERIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. NIGERIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. NIGERIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. NIGERIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 286. NIGERIA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 287. NORWAY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 288. NORWAY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 289. NORWAY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 290. NORWAY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 291. NORWAY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. NORWAY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. NORWAY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 294. NORWAY BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 295. POLAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 296. POLAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 297. POLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 298. POLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 299. POLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 300. POLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 301. POLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 302. POLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 303. QATAR BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 304. QATAR BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 305. QATAR BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 306. QATAR BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 307. QATAR BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. QATAR BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. QATAR BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 310. QATAR BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 311. RUSSIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 312. RUSSIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 313. RUSSIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. RUSSIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. RUSSIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. RUSSIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. RUSSIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 318. RUSSIA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 320. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 322. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 323. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 324. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 325. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 326. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 327. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 328. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 329. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 330. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 331. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 332. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 333. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 334. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 335. SPAIN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 336. SPAIN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 337. SPAIN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 338. SPAIN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 339. SPAIN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 340. SPAIN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 341. SPAIN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 342. SPAIN BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 343. SWEDEN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 344. SWEDEN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 345. SWEDEN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 346. SWEDEN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 347. SWEDEN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 348. SWEDEN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 349. SWEDEN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 350. SWEDEN BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 351. SWITZERLAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 352. SWITZERLAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 353. SWITZERLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 354. SWITZERLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 355. SWITZERLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 356. SWITZERLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 357. SWITZERLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 358. SWITZERLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 359. TURKEY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 360. TURKEY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 361. TURKEY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 362. TURKEY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 363. TURKEY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 364. TURKEY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 365. TURKEY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 366. TURKEY BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 367. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 368. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 369. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 370. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 371. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 372. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 373. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 374. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 375. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 376. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 377. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 378. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 379. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 380. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024-2